Flublok Quadrivalent FDA Approval History
FDA Approved: Yes (First approved October 7, 2016)
Brand name: Flublok Quadrivalent
Generic name: influenza virus vaccine, inactivated
Dosage form: Injection
Company: Protein Sciences Corp.
Treatment for: Influenza Prophylaxis
Last updated by Judith Stewart, BPharm on Oct 28, 2020.
Flublok Quadrivalent is an influenza virus vaccine indicated for active immunization against seasonal influenza in adults 18 years of age and older .
Development timeline for Flublok Quadrivalent
| Date | Article |
|---|---|
| Oct 11, 2016 | Approval FDA Approves Flublok Quadrivalent Influenza Vaccine |
| Jun 23, 2016 | Approval FDA Approved Longer Shelf Life for the Game Changer, Flublok Influenza Vaccine |
| Oct 29, 2014 | Approval Flublok Influenza Vaccine Now Approved for Adults Ages 18 and Older |
| Jan 16, 2013 | Approval FDA Approves Flublok - New Seasonal Influenza Vaccine Made Using Novel Technology |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.